Skip to main content
Figure 3 | BMC Neuroscience

Figure 3

From: Effects of creatine and β-guanidinopropionic acid and alterations in creatine transporter and creatine kinases expression in acute seizure and chronic epilepsy models

Figure 3

The effect of Tat-protein (A), Cr (B), GPA (C, E) or Tat-BCK (D) treatment on BCK (A-D) or CRT (E) immunoreactivity in the rat hippocampus. As compared to controls, Cr or Tat-BCK treatment increased BCK immunoreactivity in the rat hippocampus. GPA treatment reduced BCK and CRT immunoreactivity in ther at hippocampus. Rectangles in panels 1 indicate the regions of panels 2 and 3. Bar = 200 (panel 1) and 25 (panels 2-4) μm.

Back to article page
\